Efficacy of Tixagevimab/Cilgavimab Prophylaxis and Vaccination on Omicron Variants (BA.1, BA.2, BA.5, and BQ.1.1) in Kidney Transplant Recipients
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:18 |
---|---|
Enthalten in: |
Clinical journal of the American Society of Nephrology : CJASN - 18(2023), 10 vom: 01. Okt., Seite 1343-1345 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Bertrand, Dominique [VerfasserIn] |
---|
Links: |
---|
Themen: |
1KUR4BN70F |
---|
Anmerkungen: |
Date Completed 10.10.2023 Date Revised 03.11.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.2215/CJN.0000000000000241 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM358842301 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM358842301 | ||
003 | DE-627 | ||
005 | 20231226075616.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.2215/CJN.0000000000000241 |2 doi | |
028 | 5 | 2 | |a pubmed24n1196.xml |
035 | |a (DE-627)NLM358842301 | ||
035 | |a (NLM)37382950 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Bertrand, Dominique |e verfasserin |4 aut | |
245 | 1 | 0 | |a Efficacy of Tixagevimab/Cilgavimab Prophylaxis and Vaccination on Omicron Variants (BA.1, BA.2, BA.5, and BQ.1.1) in Kidney Transplant Recipients |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 10.10.2023 | ||
500 | |a Date Revised 03.11.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 7 | |a tixagevimab |2 NLM | |
650 | 7 | |a cilgavimab |2 NLM | |
650 | 7 | |a 1KUR4BN70F |2 NLM | |
650 | 7 | |a Antibodies, Monoclonal |2 NLM | |
700 | 1 | |a Laurent, Charlotte |e verfasserin |4 aut | |
700 | 1 | |a Lemée, Veronique |e verfasserin |4 aut | |
700 | 1 | |a Lebourg, Ludivine |e verfasserin |4 aut | |
700 | 1 | |a Hanoy, Mélanie |e verfasserin |4 aut | |
700 | 1 | |a Le Roy, Frank |e verfasserin |4 aut | |
700 | 1 | |a Nezam, Dorian |e verfasserin |4 aut | |
700 | 1 | |a Pruteanu, Diana |e verfasserin |4 aut | |
700 | 1 | |a Grange, Steven |e verfasserin |4 aut | |
700 | 1 | |a de Nattes, Tristan |e verfasserin |4 aut | |
700 | 1 | |a Lemoine, Mathilde |e verfasserin |4 aut | |
700 | 1 | |a Candon, Sophie |e verfasserin |4 aut | |
700 | 1 | |a Guerrot, Dominique |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Clinical journal of the American Society of Nephrology : CJASN |d 2006 |g 18(2023), 10 vom: 01. Okt., Seite 1343-1345 |w (DE-627)NLM172123720 |x 1555-905X |7 nnns |
773 | 1 | 8 | |g volume:18 |g year:2023 |g number:10 |g day:01 |g month:10 |g pages:1343-1345 |
856 | 4 | 0 | |u http://dx.doi.org/10.2215/CJN.0000000000000241 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 18 |j 2023 |e 10 |b 01 |c 10 |h 1343-1345 |